Biogen Idec (NASDAQ:BIIB)

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Stocks have recently hit all-time highs again, but the stock indexes seem to have gone sideways in recent days and they were looking for direction on a slow news Friday. ...
Read Full Story »

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) fits that bill despite having a $26.5 billion market cap. Is ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amazon, Biogen, Costco, Kroger, Travelers, Wayfair and Many More

Stocks were indicated to open higher on Monday, with the Dow closing on our original 2017 price target. The bull market is now over eight years old. Every instance of ...
Read Full Story »

Alexion Pharmaceuticals Adds New CFO From Biogen

Shares of Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) saw a handy gain early on Wednesday after the company announced that there would be changes in its leadership. The company announced that ...
Read Full Story »

Short Interest Surges in Major Biotechs

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotech Short Interest Remains Mixed

The short interest data are out for the most recent settlement date, April 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Huge Hedge Fund, Biotech and Technology Trades Highlight Insider Buying: Apollo Global, Biogen, Twitter, DDR and More

It’s always a sure bet that when the earnings start to slow to a trickle, the insider activity picks up as windows for top executives and 10% owners open up ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, April 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, March 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Interest Pulls Back in Major Biotechs

The short interest data are out for the most recent settlement date, March 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

March 16, 2017: The S&P 500 closed lower on the day, down 0.17% and 4.01 points to 2,381.26. Separately the DJIA closed down 0.09% on the day at 20,932.16, down ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Goldcorp, GoPro, Oracle, Sirius XM, Tyson Foods, Ciena and More

Stocks, bonds, oil and gold all rose on Wednesday after the Federal Reserved delivered on the first of likely three rate hikes in 2017. Now stocks are indicated to open ...
Read Full Story »

Major Biotechs See a Retreat in Short Interest

The short interest data are out for the most recent settlement date, February 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Stocks were indicated lower on Thursday ahead of Friday's key payrolls and unemployment report. The European Central Bank maintained rates at 0.00%. Now that the bull market is officially eight years ...
Read Full Story »